Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)
2021
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
2013
New frontiers in liver resection for hepatocellular carcinoma
2020
Non-alcoholic fatty liver disease
2017
Imaging beyond the proteome
2012 StandoutNobel
ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis
2021
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
2018
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Non-alcoholic fatty liver disease – A global public health perspective
2018 Standout
Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2015
Hepatocellular carcinoma
2016 Standout
Nonalcoholic Steatohepatitis Is Associated With Increased Mortality in Obese Patients Undergoing Bariatric Surgery
2015
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
2015 Standout
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Routine Liver Biopsy During Bariatric Surgery: an Analysis of Evidence Base
2015
Management of NAFLD: a stage-based approach
2016
Fibrosis and Adipose Tissue Dysfunction
2013 Standout
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
2022
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
2015 Standout
Alcoholic liver disease: mechanisms of injury and targeted treatment
2015
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
2014
A position statement on NAFLD/NASH based on the EASL 2009 special conference
2010
Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery
2019
Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
2012
Systemic sclerosis
2017 Standout
Therapeutic regimen of l-arginine for MELAS: 9-year, prospective, multicenter, clinical research
2018
Acute-on-chronic liver failure in cirrhosis
2016
The importance of the gut microbiota after bariatric surgery
2012
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
NAFLD and diabetes mellitus
2016
Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis
2018
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Effect of Weight Loss on Magnetic Resonance Imaging Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis
2014
Non-alcoholic fatty liver disease
2021 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
The Gordian Knot of dysbiosis, obesity and NAFLD
2013
Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity
2010
Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
2013
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Fibrosis Assessment in Nonalcoholic Fatty Liver Disease (NAFLD) in 2016
2016
Risk of type 2 diabetes in patients with non-alcoholic fatty liver disease: Causal association or epiphenomenon?
2016
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids
2018 StandoutNobel
Therapeutic Landscape for NAFLD in 2020
2020
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
2012
NAFLD in Asia—as common and important as in the West
2013
What We Talk About When We Talk About Fat
2014 Standout
Acute-on-chronic Liver Failure
2016
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
2013
Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: a Systematic Review of Liver Biochemistry and Histology
2015
Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis
2018
Non-alcoholic fatty liver disease and the interface between primary and secondary care
2018
Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans
2016
Past, present and future perspectives in nonalcoholic fatty liver disease
2019
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
2010
The bariatric surgery and weight losing: a meta-analysis in the long- and very long-term effects of laparoscopic adjustable gastric banding, laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on weight loss in adults
2017
Bariatric Surgery Provides Long-term Resolution of Nonalcoholic Steatohepatitis and Regression of Fibrosis
2020
NAFLD: A multisystem disease
2015 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Hepatocellular carcinoma
2022 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
BRAF Status of Follicular Variant of Papillary Thyroid Carcinoma and its Relationship to Its Clinical and Cytological Features
2010
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
2018 Standout
Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
2019
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
2013
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors
2013
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Genetic and epigenetic abnormalities in systemic sclerosis
2016
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Bariatric surgery for non-alcoholic steatohepatitis in obese patients
2010
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
2017
Cellular Mechanisms of Tissue Fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis
2012
Imaging sialylated tumor cell glycans in vivo
2011
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
2016
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Reduction in liver transplant wait‐listing in the era of direct‐acting antiviral therapy
2016
Nonalcoholic Steatohepatitis
2020
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Practice patterns in NAFLD and NASH: real life differs from published guidelines
2015
Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
2017 Standout
Nonalcoholic Fatty Liver Disease
2015 Standout
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
2013
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of David Buob being referenced
Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis
2015
Renal Cell Carcinoma With Rhabdoid Features: An Aggressive Neoplasm With Overexpression of p53
2007
Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease
2014
Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity
2011
Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
2015
Epithelial-to-Mesenchymal Transition Predicts Cyclosporine Nephrotoxicity in Renal Transplant Recipients
2011
A score based on microscopic criteria proposed for analysis of papillary carcinoma of the thyroid
2008
Prospective Study of the Long-Term Effects of Bariatric Surgery on Liver Injury in Patients Without Advanced Disease
2009
Volumetric Gain of the Liver after Major Hepatectomy in Obese Patients
2013
Increased Circulating miR-21 Levels Are Associated with Kidney Fibrosis
2013
MUC1 (EMA) : une molécule clé de la carcinogenèse ?
2006
Renal involvement in MELAS syndrome â a series of 5 cases and review of the literature
2012
Spectrum ofHNF1ASomatic Mutations in Hepatocellular Adenoma Differs From That in Patients With MODY3 and Suggests Genotoxic Damage
2010